Susan Shiff

Susan Shiff

Director Ejecutivo en
Huma.AI, Inc.
.

Fortuna: 7 015 $ al 30/09/2026

65 años
Health Technology
Consumer Services
Technology Services

Perfil

Susan Patricia Shiff is currently Chief Executive Officer & Director at Huma.ai, Inc. since 2024.
She is a Director at Merck Global Health Innovation Fund LLC, Director at Synthace Ltd. since 2018, Independent Director at Tvardi Therapeutics, Inc. starting in 2025, and Trustee at New Jersey Symphony Orchestra.
Former roles include Independent Director at CARA Therapeutics, Inc., Senior Vice President at Merck & Co., Inc. from 2014 to 2021, Vice President at Pfizer Inc., Vice President-Global Health Economics at Teva Pharmaceutics, and President at Ontada LLC from 2021 to 2023.
Education includes a doctorate from the University of California, Los Angeles and an MBA from Cornell University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
0,04 %
09/06/2026 5.612 ( 0,04 % ) 7 015 $ 30/09/2026

Cargos activos de Susan Shiff

EmpresasCargoInicio
Director/Miembro de la Junta 05/06/2018
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director Ejecutivo 01/07/2024

Antiguos cargos conocidos de Susan Shiff.

EmpresasCargoFin
Presidente 01/07/2023
MERCK & CO., INC. Corporate Officer/Principal 01/03/2021
PFIZER INC. Corporate Officer/Principal -
Teva Pharmaceutics
Corporate Officer/Principal -
CARA THERAPEUTICS, INC. Director/Miembro de la Junta -
Ver el detalle de la experiencia de Susan Shiff.

Formación de Susan Shiff.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

80

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Teva Pharmaceutics

Finance

Technology Services

Technology Services

Health Services